ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 12th, 2010 • RegenoCELL Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledApril 12th, 2010 Company IndustryThis Asset Purchase Agreement (this "Agreement") is made on 5 January, 2010, by and between Regenocell Laboratories Ltd, a company under incorporation under the laws of the state of Israel ("Regenocell", the "Buyer"), and TheraVitae Limited, a company incorporated under the laws of the state of Israel (the "Seller").
Contract for ASSIGNMENT OF RIGHTS between YIELDEX LTD. as Assignor and REGENOCELL THERAPEUTICS, INC. as Assignee dated as of 31st December 2009 SIAM PREMIER INTERNATIONAL LAW OFFICE LIMITED 26th Floor, The Offices at Central World, 999/9 Rama I Road,...Assignment of Rights • April 12th, 2010 • RegenoCELL Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 12th, 2010 Company Industry JurisdictionYIELDEX, LTD., a company duly incorporated in Hong Kong (as defined below) with its registered office at Basement, Kwong Loong Tai Building, 1016 Tai Nam West Street, Hong Kong and represented by its sole director, Ms Mak Hing Fang , office number: +852 (2744) 8714 and email: cleung@sifa.com.hk (the "Assignor") and